<![CDATA[How Toragen's Alignment With The Gates Foundation Supports Global Access and Commercialization]]>
In the third part of her interview with Pharmaceutical Executive, Sandra Coufal, MD, CEO of Toragen, traces the origins of the company’s relationship with The Gates Foundation through a 21-year history with the foundation via the Novartis Research …